US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

39.83

-0.1700-0.43%

Post-market: 39.830.00000.00%16:10 EDT

Volume:45.67K

Turnover:1.82M

Market Cap:270.84M

PE:- -

High:40.20

Open:40.12

Low:39.71

Close:40.00

52wk High:41.49

52wk Low:22.33

Shares:6.80M

Float Shares:6.80M

Volume Ratio:0.49

T/O Rate:0.67%

Dividend:0.28

Dividend Rate:0.70%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target

MT Newswires Live

Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs

Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Moderna Price Target Announced at $180.00/Share by Argus Research

U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Moderna Prices $2.6 Billion Convertible Notes due 2032

MT Newswires Live

Moderna Rises After Upsized $2.6 Bln Convertible Bond Sale

Incyte Partner Knight Seeks Supplemental Approval for Minjuvi Combination in Brazil

MT Newswires Live

US Regulator Approves Novel Pancreatic Cancer Therapy, Marking Major Win for Independent Biotech

Why the Drugmaker Behind a Pancreatic Cancer Breakthrough Stayed Independent

FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech

Moderna Inc. Stock Slips 4.6%, Underperforms Peers

Twist Bioscience CEO Emily Leproust Sells USD 6.28 Million in Common Shares

Moderna Wins FDA Approval for Updated 2026-2027 COVID-19 Vaccines Targeting JN.1-Lineage XFG Subvariant

Moderna - FDA Approved Sbla for 2026-2027 Formulas for Spikevax and Mnexspike

THOMSON REUTERS

Moderna - Updated Formula for Spikevax is NOW Approved for Individuals 6 Months Through 64 Years of Age with at Least One Underlying Condition

THOMSON REUTERS

Moderna: Updated Covid-19 Vaccines Expected Available in Coming Days

THOMSON REUTERS

Moderna Inc Stock (MRNA) Moved Down by 5.69% on Aug 27: Key Drivers Unveiled

Sector Update: Healthcare

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/IDNA/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":39.83,"timestamp":1789761600000,"preClose":40,"halted":0,"volume":45673,"hourTrading":{"tag":"盘后","latestPrice":39.83,"preClose":39.83,"latestTime":"16:10 EDT","volume":6617,"amount":263555.11,"timestamp":1789762203995,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.004250000000000043,"floatShares":6800000,"shares":6800000,"eps":0,"marketStatus":"Post-Mkt","change":-0.17,"latestTime":"09-18 17:56:43 EDT","open":40.12,"high":40.2,"low":39.7101,"amount":1821020,"amplitude":0.012248,"askPrice":43.25,"askSize":100,"bidPrice":34.02,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789776000000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":40,"sharesOutstanding":5100000,"nav":38.722209,"aum":263311021.2,"dividendRate":0.00703,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":40.9,"preClose":40,"latestTime":"09:14 EDT","volume":25,"amount":1017.07,"timestamp":1789737274853,"change":0.9,"changeRate":0.0225,"amplitude":0.03025},"postHourTrading":{"tag":"盘后","latestPrice":39.83,"preClose":39.83,"latestTime":"16:10 EDT","volume":6617,"amount":263555.11,"timestamp":1789762203995,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.490286,"impliedVol":0.2131,"impliedVolPercentile":0.5458},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6800000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.490286,"shares":6800000,"dividePrice":0.28,"high":40.2,"amplitude":0.012248,"preClose":40,"low":39.7101,"week52Low":22.33,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":39.83,"eps":0,"divideRate":0.00703,"volume":45673,"delay":0,"ttmEps":0,"open":40.12,"prevYearClose":26.19,"prevWeekClose":38.06,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":38.06,"twentyDayClose":39.29,"sixtyDayClose":31.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662098660","title":"Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098660","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098660?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:20","pubTimestamp":1787919631,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $96.47, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4501","BK4532","MRNA","MRNX","LGHT","BK4139","WDNA","BK4588","GNOM","MRNY","BK4568","BK4551","IDNA","BK4548","BK4533","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098595","title":"Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098595","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098595?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:15","pubTimestamp":1787919300,"startTime":"0","endTime":"0","summary":"Company Strengthens Global Intellectual Property Portfolio with 28 Issued and 30 Pending PatentsDOYLESTOWN, Pa., Aug.  28, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/28/3352669/0/en/aprea-therapeutics-announces-expansion-of-intellectual-property-portfolio-for-precision-oncology-programs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","MEDX","BMED","GDOC","BK4139","BK4539","BK4007","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662060019","title":"Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662060019","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662060019?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:12","pubTimestamp":1787919133,"startTime":"0","endTime":"0","summary":"BRIEF-Moderna Announces Pricing Of Upsized $2.6 Billion Offering Of Convertible Senior NotesAug 28 -Moderna IncMRNA.O:MODERNA: MODERNA ANNOUNCES PRICING OF UPSIZED $2.6 BILLION OFFERING OF CONVERTIBLE SENIOR NOTESMODERNA: PURCHASED HEDGE OVERLAY INTENDED TO OFFSET DILUTION UP TO CAP INITIALLY EQUAL TO 175.0% PREMIUM TO STOCK PRICE AT PRICINGSource text: [ID:]Further company coverage:MRNA.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P0W5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","BK4139","BK4585","BK4588","BK4501","BK4551","MRNY","BK4548","WDNA","BK4534","MRNX","BK4568","BK4533","IDNA","MRNA","BK4532","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662060438","title":"Moderna Price Target Announced at $180.00/Share by Argus Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2662060438","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662060438?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:00","pubTimestamp":1787918400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MRNA/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BK4585","GNOM","MRNY","BK4551","BK4568","LGHT","IDNA","WDNA","BK4534","BK4532","BK4588","BK4139","BK4501","BK4548","BK4533","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662677510","title":"U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty","url":"https://stock-news.laohu8.com/highlight/detail?id=2662677510","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662677510?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:41","pubTimestamp":1787917296,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna, Ulta BeautyAugust 28 (Reuters)-Futures tied to the S&P 500 and Nasdaq inched lower on Friday after Nvidia's stellar forecast sparked a technology ra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL6N44P0MR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2413666699.HKD","LU2265009873.SGD","LATR","LU0390134368.USD","LU1983260115.SGD","GAMR","LU0345774631.USD","IE00BMPRXN33.USD","LU2237443382.USD","IE000KEQY171.SGD","LU0557290698.USD","SG9999015358.SGD","LU2238339852.HKD","LU2420271590.USD","TTEQ","LU0323591593.USD","LU1645745479.HKD","WISE","LU2430703251.USD","BK4503","IE00B775H168.HKD","LU0106261372.USD","LU1629891620.HKD","LU2191332357.HKD","LU2491049909.HKD","BK4534","BK4528","LU2237957902.USD","LU2506951792.HKD","LU0942090050.USD","LU0795875169.SGD","BK4539","BK4592","LU2054465674.USD","LU0127658192.USD","LU2272731782.SGD","TRFK","LU1868837300.USD","LU0079474960.USD","LU2746668974.SGD","NVD","LU0308772762.SGD","IE00BKVL7J92.USD","JGRO","LU1116320901.HKD","LU2322448791.USD","LU2148611432.USD","IE00BMPRXR70.SGD","LU1035775433.USD","LU1791710582.SGD","LU2552382132.HKD","IE0004445239.USD","LU0238689110.USD","LU1037948897.HKD","LU0158827781.USD","LU0820561818.USD","SOXQ","LU0965509101.SGD","LU0823421416.USD","VT","LU0077335932.USD","PYPG","LU0198837287.USD","LU0276348264.USD","LU0472753341.HKD","NERD","LU1267930730.SGD","LU0109391861.USD","BK4549","LU0868494617.USD","FTEC","LU2750360641.GBP","NVD3.UK","BK4023","HK0000306685.HKD","LU2065171311.SGD","PYPU","LU0316494557.USD","LU1974910355.USD","LU2023250504.SGD","BK4543","LU2271345857.HKD","IREX","LU2237438978.USD","LU1699723380.USD","LU1244550577.SGD","LU0080751232.USD","LU1069344957.HKD","LU1069347547.HKD","LU2637965513.SGD","LU2236285917.USD","LU1989772840.SGD","LU2394011477.USD","MRNY","LU1066051811.HKD","LU2360032135.SGD","LU0267386448.USD","LU1668664300.SGD","LU1720051108.HKD","LU0133085943.USD","LU1496350171.SGD","LU2092937148.SGD","ESUM","RSPC","SNVDAmain","LU2242649171.HKD","LU1084165304.USD","LU2543165471.USD","LU1400636657.SGD","LU1934455277.USD","LU0053666078.USD","IE00BHPRN162.USD","LU1868836591.USD","LU2133065610.SGD","LU2458330243.SGD","LU2097344357.USD","S","LU1366192091.USD","LU1732799900.SGD","LU0353189680.USD","LU0210528500.USD","BK4548","IE00BQXX3D17.EUR","LU0203202063.USD","LU0724617625.USD","AIFD","IE000YTNTUN2.SGD","HK0000304805.HKD","LU1066053197.SGD","LU1571399168.USD","SG9999014898.SGD","LU1144417596.USD","LU2272731865.HKD","SG9999014880.SGD","BK4516","LU2322448957.HKD","LU0174119429.USD","IE00B19Z8W00.USD","LU2213496289.HKD","LU0057025933.USD","LU0965509283.SGD","LU2360107168.USD","LU1548497426.USD","DAPP","LU0061475181.USD","LU1691799644.USD","LU2452424414.USD","LU1720051017.SGD","LU2089283258.USD","BK4588","LU0211327993.USD","LU1934455194.USD","LU1261432733.SGD","LU2294711713.HKD","IE0034235295.USD","LU0417517546.SGD","LU2471134952.CNY","BK4109","LU2087625088.SGD","LU2237443978.SGD","SHOC","LU0256863902.USD","LU2083900584.USD","METV","IE00BN29S564.USD","LU2298064838.USD","LU0466842654.USD","LU0642271901.SGD","IE00B5949003.HKD","LU1861220033.SGD","BK4579","LU0215105999.USD","IE00BMPRXQ63.HKD","TEK","LU2326559502.SGD","LU1815333072.USD","GNOM","IE00B4YYXB79.USD","LU1880398471.USD","NVII","LU1623119135.USD","LU1235294995.USD","LU2360106780.USD","TTXU","CLSE","IE00B1BXHZ80.USD","SMHX","ANV","LU1989764664.SGD","HK0000532082.HKD","LU2063271972.USD","AGOX","LTL","LU0143551892.USD","LU1127390331.HKD","WDNA","LU0795875086.SGD","LU2360107671.USD","SGXZ99366536.SGD","SG9999001424.SGD","XLK","THMR","IE00BFSS8Q28.SGD","LU0348723411.USD","MNRS","IREN","HK0000320264.USD","LU2347655156.SGD","ROM","LU2125909247.SGD","LU1119994496.HKD","BK4141","LU0444971666.USD","LU1935042991.SGD","LU1674673428.USD","LU0719512351.SGD","LU1951200564.SGD","TYLG","IREZ","LU0187121727.USD","LU0689472784.USD","IE00BQXX3C00.GBP","LU0353189763.USD","IE00B894F039.SGD","LU2125910336.SGD","LU0640476718.USD","LU0426417589.USD","LU0347712357.USD","SGXZ51526630.SGD","LU0323239441.USD","LU0511384066.AUD","HK0000819398.USD","LU1868837136.USD","MRNA","HK0000304797.USD","LU0138981039.USD","LU2896262040.SGD","FAI","ARTY","LU2403377893.USD","STCE","LU0342679015.USD","WGMI","NVDS.UK","SG9999014906.USD","SG9999015952.SGD","LU0345774391.USD","LU0094547139.USD","IE00B775SV38.USD","LU2357305700.SGD","LU1400636491.USD","HK0000306701.USD","LU0823414478.USD","LU1823568750.SGD","LU1988902786.USD","LU0081259029.USD","LU1202635105.USD","LU0726765562.USD","HK0000914686.HKD","LU2487616109.SGD","LU1066051225.USD","IDNA","BK4560","IE00BZ9MQY76.HKD","BK4106","LU1861215975.USD","IE00BDCRKT87.USD","LU2552382058.USD","NVDW","LU2168564495.EUR","LU0157215616.USD","LU0289961442.SGD","LU2242650005.HKD","BK4097","LU0965509010.AUD","LU2361044949.HKD","LU2471134879.HKD","LU1366333091.USD","LU2430703178.SGD","NVDG","LU2463028550.USD","LU2750360997.AUD","IE0034235188.USD","IE00B3SWFQ91.USD","BK4567","IE00B19Z9P08.USD","LU2247934214.USD","IE00BWXC8680.SGD","LU2462591350.SGD","IE0003U64NQ7.SGD","IE00BZ199S13.USD","SMH","LU1939255532.USD","BK4524","LU1244550494.USD","LU1046421795.USD","IE00B5TLWC47.USD","LU2417539215.USD","SG9999018857.SGD","LU0957808578.USD","LU0225283273.USD","USXF","BK4554","LU1861217088.USD","ESPO","LU2168563687.JPY","LU0048584097.USD","IE00BJJMRY28.SGD","LU0265550359.USD","IE0009G5SDU7.USD","LU0310800379.SGD","DIPS","LU2237443622.USD","LU2473716301.USD","GAP","LU2552382215.SGD","LU1242518857.USD","LU1718418525.SGD","LU0345769631.USD","SG9999015986.USD","LU1989772923.USD","LU2462157665.USD","LU2237443895.HKD","LU2602419157.SGD","LU1674673691.USD","SOLS","LU1169590202.USD","HK0000320223.HKD","LU1821325948.USD","LU1244550221.USD","LU0345769128.USD","BK4568","AIPI","LU1934455863.HKD","LU2211815571.USD","LU0097036916.USD","LU0158827948.USD","LU0823421333.USD","BK4585","LU0107464264.USD","LU1917777945.USD","LU0210533765.USD","SOXX","LU0310799852.SGD","LU0786609619.USD","SGXZ23171101.USD","IE00BYXW3230.USD","LU0708995401.HKD","LU0274383776.USD","LU1992135472.HKD","BK4535","BK4614","NVDS","LU2491050071.SGD","LU1043141396.HKD","LU1003077747.HKD","LU0979878070.USD","LU2931357623.SGD","VGT","IE00BZ1G4Q59.USD","BK4561","07788","MRNX","IE00B3M56506.USD","LU0170899867.USD","BK4612","LU2250418816.HKD","NVDO","LU0234572021.USD","NVDU","LU0823434583.USD","LU0553294199.USD","BK4581","LU0661504455.SGD","IE0034235303.USD","LU1551013425.SGD","LU1868836757.USD","BK4139","BK4587","IREG","LU0868494708.USD","LU0683600562.USD","SG9999014575.USD","LU1861220207.SGD","LU1923621640.USD","LU2237957811.SGD","BK4527","LU1951198990.SGD","BNGE","IE00BK4W5L77.USD","LU0056508442.USD","IE0004091025.USD","LU2471134796.USD","NVDA","SG9999014542.SGD","LU2237443549.SGD","QNRX","LU1935043023.USD","HK0000914660.USD","LU0957791311.USD","LFGY","LU1721428933.USD","LU2361044865.SGD","IE00BJJMRX11.SGD","07388","LU2100268510.USD","LU2168564222.USD","LU0964807845.USD","GB00BDT5M118.USD","LU2089985449.USD","BK4550","LU1642822529.SGD","LU0345770993.USD","LU1066051498.USD","LU2108987350.USD","LU2111349929.HKD","LU0889565833.HKD","LU2279689827.SGD","LU0289739343.SGD","BITQ","LU2999663052.SGD","IRE","ADSK","IE00BJLML261.HKD","SGXZ81514606.USD","LU0689626769.HKD","IE000Q6AESB8.SGD","BK4551","BK4532","CYTK","LU0011850046.USD","LU0823411888.USD","LU2125909759.SGD","SG9999015978.USD","IE00BKDWB100.SGD","LU0788109477.HKD","LU2237443465.HKD","3NVD.UK","LU2462591277.SGD","LU0096362180.USD","SG9999002232.USD","LU1267930490.SGD","LU2456880835.USD","ILDR","LU2430703095.HKD","LU1400636574.HKD","LU2756315664.SGD","IBLC","SOXY","LU0124676726.USD","LU2125154778.USD","CHAT","IE000ITXATA3.USD","IE00B7KXQ091.USD","BK4227","IE00B1XK9C88.USD","LU2264538146.SGD","LU0345768740.USD","IETC","LU1323610961.USD","SGXZ31699556.SGD","LU0476273544.USD","LU0070217475.USD","LU0820562030.AUD","LU2433249047.HKD","SG9999002224.SGD","LU1169589451.USD","LU0345770308.USD","LU1992135399.USD","CNEQ","BK4505","LU2077746001.SGD","LU0210536198.USD","NVDY","BK4598","NVDX","LU1712237335.SGD","LGHT","IE00BD6J9T35.USD","LU2125910179.SGD","NVDL","IE00BJTD4N35.SGD","NVDQ","BK4533","LU0203201768.USD","FDTX","IE00BFSS7M15.SGD","LU2023251221.USD","SG9999014567.USD","IE00BK4W5M84.HKD","LU2065169927.USD","BKCH","BK4566","IE00B19Z9505.USD","LU2347655073.USD","LU0823414551.USD","LU1232071149.USD","LU0234570918.USD","LU0096364046.USD","LU0320765059.SGD","LU1633808545.USD","IE00B19Z8X17.USD","PYPL","LU1923622614.USD","LU1496350502.SGD","LU0082616367.USD","SG9999004303.SGD","LU2954938101.SGD","LU1778281490.HKD","LU2413666426.HKD","IXN","IE000W1ABFV2.USD","IE00BJTD4V19.USD","LU2023250330.USD","LU0323240290.USD","NVD2.UK","LU0289960550.SGD","LU0861579265.USD","SG9999015341.SGD","NVIW.SI","LU0354030438.USD","LU1935042488.USD","PYPY","SNVD.UK","LU2381873111.SGD","LU1035773651.USD","LU0128525929.USD","LU1116320737.USD","LU2106854487.HKD","LU2756315318.SGD","LU1732800096.USD","LU1121112475.USD","LU2168564065.EUR","LU0175139822.USD","LU0251132253.USD","LU2860962120.EUR","CHPX","LU0994945656.USD","BK4501","LU1242518931.SGD","ESLG","BK4094","SGXZ80539844.SGD","LU2092627202.USD","LU0211328371.USD","LU1316542783.SGD","LU0354030511.USD","SG9999018865.SGD","SNPE","LU0985320562.USD","BK4085","LU0061474960.USD","SG9999017495.SGD","LU2361045086.USD","LU0943347566.SGD","BK4529","LU2471134523.USD","FDIG","IE0005OL40V9.USD","LU2065170008.USD","IE00B19Z9Z06.USD","IE0009356076.USD","LU1267930573.SGD","LU2505996681.GBP","LU2125909593.SGD","LU2272731600.USD","XLC","LU2125154935.USD","SG9999014559.SGD","LU0395794307.EUR","LU1880398554.USD","AFRU","IE00BKPKM429.USD","LU0545039389.USD","LU0672654240.SGD","IE00BDRTCR15.USD","LU1153585028.USD","LU2290526834.HKD","LU2458330169.SGD","LU1791807156.HKD","SG9999000418.SGD","LU0820561909.HKD","LU2244417387.USD","LU1791710400.SGD","LU2592432038.USD","BTAI","LU2047632596.USD","LU0266013472.USD","LU1989764748.USD","LU1670756490.USD","LU2461242641.AUD","LU0444973449.USD","NULC","LU0912757837.SGD","LU2125909916.SGD","LU1803068623.USD","LU1868836914.USD","ABFL","LU0823434740.USD","LU0345768153.USD","LU1803068979.SGD","AFRM","LU0528227936.USD","LU0965508806.USD","BK4608","LU2089284900.SGD","LU2028103732.USD","LU0109392836.USD","LU1914381329.SGD","LU1935043536.SGD","FINX","EFIV","BK4200","SPTE","LU0949170772.SGD","LU1852331112.SGD","LU0426412945.USD","LU2168564149.EUR","LU1429558221.USD","LU0882574139.USD","LU1145028129.USD","IREC","LU1923623000.USD","LU2505996509.AUD","NVDD","CMAG","LU0029864427.USD","LU2249611893.SGD","LU1935042215.USD","BK4605","LU1814569148.SGD","BK4595","LU2286300806.USD","LU1043141123.HKD","LU2746668461.USD","LU1861127337.USD","LU0738911758.USD","HERO","IE00BQXX3F31.USD","LU0787776722.HKD","NVC","LU1804176565.USD","SG9999015945.SGD","LU1037948541.HKD","IE0001KFT4U8.USD","STBQ","LU0256863811.USD","LU2357125470.USD","SG9999014914.USD","NVDB","TTWO","LU0069063385.USD","LU0494093205.USD","LU0072462426.USD","LU0265550946.USD","IPAY","LU1551013342.USD","LU2097344431.USD","LU2087621335.USD","LU1923622291.USD","LU1064131342.USD","LU1435385759.SGD","BK4600","IE0004086264.USD","LU0006306889.USD","IE00B4JS1V06.HKD","LU0061474705.USD","IE0004445015.USD","LU1839511570.USD","LU0154236417.USD","LU0708994859.HKD","LU1815336760.USD","NVYY","LU1280957306.USD","LU1979441026.SGD","LU2065171402.SGD","LU0106831901.USD","2NVD.UK","LU3102509885.SGD","USD","IE00B3S45H60.SGD","ULTA","LU2491050154.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662667970","title":"Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough","url":"https://stock-news.laohu8.com/highlight/detail?id=2662667970","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662667970?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:30","pubTimestamp":1787916600,"startTime":"0","endTime":"0","summary":"An mRNA cancer vaccine Moderna had been developing with Merck had hit its mark — the first success of a therapeutic cancer vaccine in late-stage testing after more than 100 years of failed attempts.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44N0PO:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051811.HKD","LU0238689110.USD","LU0266013472.USD","LU2324357040.USD","LU2461242641.AUD","MRK","LU1035773651.USD","LU0203347892.USD","BK4534","PPH","IE00BLSP4452.SGD","LU0203345920.USD","LU0289739699.SGD","LU0859254822.USD","LU0432979614.USD","BK4585","LU2106854487.HKD","LU2361045086.USD","LU1066051498.USD","IE00B2B36J28.USD","IE00BLSP4239.USD","LU1037948541.HKD","LU1934455194.USD","LU1093756168.USD","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU1989772923.USD","RXL","LU0265550359.USD","LU1057294990.SGD","SG9999001176.USD","LU1116320737.USD","GNOM","LU1023059063.AUD","LU1430594728.SGD","BK4533","BK4550","LU1093756325.SGD","SGXZ57979304.SGD","LU2125154778.USD","LGHT","FTXH","LU1162221912.USD","LU1571399168.USD","LU0098860793.USD","BK4516","LU2491050154.USD","LU0868494708.USD","LU0106261372.USD","LU0070302665.USD","LU1291159041.SGD","LU0124676726.USD","BK4568","LU1116320901.HKD","LU1929549753.HKD","SG9999013999.USD","BK4588","IE00B4R5TH58.HKD","LU0965509101.SGD","LU0130102774.USD","LU0006306889.USD","LU0980610538.SGD","LU1066051225.USD","MRNY","IXJ","LU1934455863.HKD","LU0823416689.USD","LU2357627491.SGD","SG9999014575.USD","WDNA","PAWZ","SG9999014559.SGD","SG9999001176.SGD","HRTS","XLV","IHE","LU2491049909.HKD","LU1941712348.USD","LU1923622614.USD","LU0320765489.SGD","LU1201861249.SGD","LU0208291251.USD","IDNA","LU0320765646.SGD","LU0477156953.USD","BK4551","BK4559","BK4007","FHLC","TRUH","LU2125909247.SGD","SG9999014542.SGD","LU2125154935.USD","LU0122379950.USD","IE0009355771.USD","LU0689626769.HKD","LU1069347547.HKD","BMED","LU0965508806.USD","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","LU0942090050.USD","LU0985320562.USD","BK4532","BK4501","LU1061106388.HKD","LU2361044865.SGD","SG9999014567.USD","LU2023250504.SGD","LU0265550946.USD","IE00BJT1NW94.SGD","IE00B1BXHZ80.USD","IYH","LU1989771016.USD","LU2361044949.HKD","LU1699723380.USD","LU0648001328.SGD","BK4139","LU1974910355.USD","SG9999001440.SGD","IE00BN8TJ469.HKD","LU1989772840.SGD","LU0130517989.USD","LU1037948897.HKD","MRNX","LU0965509283.SGD","BK4548","LU0861579265.USD","LU0965509010.AUD","SG9999002224.SGD","GDOC","LU0868494617.USD","LU1941712264.USD","JDOC","LU1983299246.USD","LU2112291526.USD","SG9999015358.SGD","SG9999015341.SGD","IE0002141913.USD","IE00BBT3K403.USD","LU2360032135.SGD","LU2089984988.USD","LU0058720904.USD","LU2433249047.HKD","LU1066053197.SGD","LU2491050071.SGD","LU0211331839.USD","LU0234572021.USD","LU1585245621.USD","MRNA","LU1934455277.USD","LU2023250843.SGD","LU2125909593.SGD","VHT","IE00BSNM7G36.USD","SG9999002232.USD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662389067","title":"Moderna Prices $2.6 Billion Convertible Notes due 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=2662389067","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662389067?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:23","pubTimestamp":1787916190,"startTime":"0","endTime":"0","summary":"Moderna  priced a $2.6 billion offering of convertible senior notes due 2032, up from the previously announced $2 billion, the company said Friday.Initial purchasers were granted an option to buy up to an additional $400 million of notes, the company said.The company expects to use the net proceeds to pay the cost of certain capped call transactions and for general corporate purposes, including potential investments in its oncology business and debt repayment, it added.The company expects the sale to initial purchasers to close Tuesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","MRNY","GNOM","LGHT","MRNA","WDNA","BK4534","BK4551","BK4568","BK4548","BK4588","BK4585","BK4501","BK4533","IDNA","BK4139","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662062748","title":"Moderna Rises After Upsized $2.6 Bln Convertible Bond Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2662062748","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662062748?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:19","pubTimestamp":1787915947,"startTime":"0","endTime":"0","summary":"BUZZ-Moderna rises after upsized $2.6 bln convertible bond sale** Biotech firm Moderna'sMRNA.Oshares up 1.2% at $144.50 before the bell on Fri after it raises more capital than planned** Cambridge, Massachusetts-based MRNA announces pricing private offering of $2.6 bln 0% convertible bonds due March 1 2032** Conversion price of $210.58 represents 47.5% premium over stock's last close of $142.77** MRNA shares finished down 4.6% on Thurs after counveiled$2 bln offering for general corp purposes, including to grow its oncology business and repay debt** Co expects to use approx $285 mln of net proceeds to pay cost of capped call transactions; cap price of $392.62 is 175% above stock's last sale** On Aug 19, MRNA shares soared 177% to $174.38, a 3-1/2 year high, after co said itsskin cancer vaccine, combined with Merck'sMRK.NKeytruda, reduced risk of recurrence and spread of melanoma in a late-stage trial** Through Thurs, MRNA shares up 384% YTD** Avg rating of 23 analysts is \"hold\"; median","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL6N44P0MB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","BK4533","BK4548","BK4532","BK4585","MRNA","MRNX","BK4139","BK4568","BK4588","GNOM","WDNA","LGHT","BK4551","IDNA","BK4501","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662061139","title":"Incyte Partner Knight Seeks Supplemental Approval for Minjuvi Combination in Brazil","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061139","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061139?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:26","pubTimestamp":1787912783,"startTime":"0","endTime":"0","summary":"Incyte  partner Knight Therapeutics has submitted a supplemental application to the Brazilian health regulatory agency seeking approval for an additional indication for Minjuvi in combination with other medicines as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma or high-grade B-cell lymphoma, the company said Thursday.The drug combination consists of Minjuvvi and lenalidomide added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, the company said.The application is meant to expand Minjuvi in earlier lines of cancer therapy in Brazil, the company said.The supplemental submission is based on previous approvals and results from a phase 3 trial, the company said.Knight has exclusive supply and distribution rights for Incyte's Minjuvi, which is also called Monjuvi, in the US and parts of Latin America, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INCY","BK4585","BK4550","EWZS","IDNA","BK4532","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145744656","title":"US Regulator Approves Novel Pancreatic Cancer Therapy, Marking Major Win for Independent Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=1145744656","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145744656?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:24","pubTimestamp":1787912643,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration has officially approved Revolution Medicines' self-developed pancreatic cancer treatment, Rasonque, this week. This approval represents a significant triumph for...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0109394709.USD","IE00BJT1NW94.SGD","BK4588","BK4585","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IDNA","BBH","BK4139","PTH","IE0002141913.USD","RVMD","IE0009354923.USD","IE0009355771.USD","LABU","LU0320765992.SGD","IE00BJJMRZ35.SGD","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662037671","title":"Why the Drugmaker Behind a Pancreatic Cancer Breakthrough Stayed Independent","url":"https://stock-news.laohu8.com/highlight/detail?id=2662037671","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662037671?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:21","pubTimestamp":1787880060,"startTime":"0","endTime":"0","summary":"Earlier this year, an oncology biotech with no drugs on the market-just promising research-was attracting takeover interest. Revolution Medicines stayed independent.This week, that bet paid off.The 12","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00BJJMRZ35.SGD","IDNA","IE0002141913.USD","IE0009354923.USD","IE00B4R5TH58.HKD","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","RVMD","CANC","BK4139","IE00B2B36J28.USD","PTH","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035516","title":"FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035516","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662035516?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:04","pubTimestamp":1787864640,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration approved new seasonal Covid-19 vaccine formulas made by Moderna, Pfizer and BioNTech.The agency gave a green light to supplemental biologics license applications for the 2026-2027 formulas to the Comirnaty vaccine, made by Pfizer and BioNTech, and Moderna's mNexspike and Spikevax shots. The new formulas are designed to target the XFG variant of Covid-19.Pfizer and BioNTech said the new formulation of its vaccine would begin shipping immediately for use beginning in the fall. Moderna said its updated vaccines will be available in the coming days.All three vaccines were approved for adults 65 years of age and older. The FDA also approved the shots for individuals younger than 65 whose underlying conditions put them at high risk for severe outcomes from Covid-19. Those approvals extend as young as 12 years old for mNexspike, five years for Comirnaty, and six months for Spikevax.\"Our updated COVID-19 vaccines help protect those at high risk of severe diseas","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","MRNA","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0122379950.USD","IE00B19Z3581.USD","LU0456855351.SGD","BK4533","IE00BLSP4452.SGD","BK4588","LU0225771236.USD","LU1057294990.SGD","BK4532","LU1066051498.USD","SG9999002224.SGD","LU0321505439.SGD","BK4550","LU0170899867.USD","SG9999001176.USD","BK4568","LU0058720904.USD","BK4585","IE0002270589.USD","IE00BBT3K403.USD","OZEM","IDNA","LU0234572021.USD","WDNA","SG9999002232.USD","LGHT","LU1894683264.USD","LU2596442595.SGD","BK4599","LU0306806265.USD","MRNY","BK4535","BK4548","LU0289739699.SGD","BNTX","BK4139","GNOM","LU1883839398.USD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU1894683348.USD","BK4501","BK4592","LU0868494617.USD","SG9999001176.SGD","SG9999011175.SGD","LU1023059063.AUD","LU1066053197.SGD","BK4534","SG9999013999.USD","BK4581","BK4007","LU0985481810.HKD","LU0321505868.SGD","IE000M9KFDE8.USD","LU0306807586.USD","MRNX","BK4551","IE00B3T34201.USD","PFE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033626","title":"Moderna Inc. Stock Slips 4.6%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033626?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:34","pubTimestamp":1787862840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 4.6% to $142.77 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.6% to 26,541.35 and the Dow Jones Industrial Average rising 0.2% to 53,569.44.This was the stock's second consecutive day of losses.Moderna Inc. closed 19.2% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.6% to $265.77, Pfizer Inc. fell 1.0% to $28.02, and Gilead Sciences Inc. rose 0.52% to $148.86.Trading volume totaled 24.9 million, compared to the 50-day average of 16.4 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","SG9999015952.SGD","LU1571399168.USD","IDNA","IE00B7SZLL34.SGD","WDNA","BK4139","LU1674673428.USD","IBBQ","LU1934455194.USD","LU0965509283.SGD","LU2357627491.SGD","MRNX","GNOM","BMED","BK4551","LU0320765992.SGD","BK4550","LU2324357040.USD","MRNA","LU1674673691.USD","BK4534","LU1061106388.HKD","LU0965508806.USD","LU2468319806.SGD","LU0109394709.USD","LU0861579265.USD","TBXU","BK4568","IE00BKVL7J92.USD","LU0889565916.HKD","LU0058720904.USD","LGHT","MRNY","BK4588","BIB","LU0114720955.EUR","TMED","SG9999015945.SGD","GILD","LU1037948541.HKD","MEDI","BK4583","SG9999015986.USD","LU1934455277.USD","BK4533","IE00B19Z3581.USD","LU0965509010.AUD","BBH","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662403857","title":"Twist Bioscience CEO Emily Leproust Sells USD 6.28 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662403857","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662403857?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:06","pubTimestamp":1787861174,"startTime":"0","endTime":"0","summary":"Twist Bioscience CEO Emily Leproust sells USD 6.28 million in common sharesTwist Bioscience CEO Emily M. Leproust sold 41,570 shares on Aug. 25, 2026 at $150.56 to $154.45.Direct holdings fell to 770,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL4CsHyC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience CEO Emily Leproust Sells USD 6.28 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GNOM","ARKG","BK4139","BK4585","WDNA","IDNA","TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080060","title":"Moderna Wins FDA Approval for Updated 2026-2027 COVID-19 Vaccines Targeting JN.1-Lineage XFG Subvariant","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080060","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080060?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860727,"startTime":"0","endTime":"0","summary":"Moderna wins FDA approval for updated 2026-2027 COVID-19 vaccines targeting JN.1-lineage XFG subvariantFDA cleared Moderna’s updated 2026-2027 COVID-19 vaccine formulas targeting the JN.1-lineage XFG ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL395HN3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4533","BK4551","IDNA","LGHT","BK4585","MRNX","WDNA","BK4139","BK4501","BK4588","GNOM","MRNA","BK4568","BK4548","BK4534","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662800610","title":"Moderna - FDA Approved Sbla for 2026-2027 Formulas for Spikevax and Mnexspike","url":"https://stock-news.laohu8.com/highlight/detail?id=2662800610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662800610?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860725,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O15C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4533","MRNA","BK4534","BK4588","WDNA","BK4551","LGHT","IDNA","BK4568","MRNY","BK4139","GNOM","BK4532","BK4585","MRNX","BK4548","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080096","title":"Moderna - Updated Formula for Spikevax is NOW Approved for Individuals 6 Months Through 64 Years of Age with at Least One Underlying Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080096","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080096?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860725,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O15C:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4534","BK4533","BK4568","GNOM","IDNA","BK4585","LGHT","BK4548","MRNX","BK4501","MRNY","BK4551","BK4139","MRNA","WDNA","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080095","title":"Moderna: Updated Covid-19 Vaccines Expected Available in Coming Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080095?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860725,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O15C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4551","BK4568","IDNA","MRNA","BK4533","WDNA","BK4588","MRNY","LGHT","BK4534","BK4139","BK4548","BK4501","BK4532","BK4585","GNOM","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662808054","title":"Moderna Inc Stock (MRNA) Moved Down by 5.69% on Aug 27: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2662808054","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662808054?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:15","pubTimestamp":1787858128,"startTime":"0","endTime":"0","summary":"• Moderna announced a proposed two billion dollar convertible senior notes private placement.\n• The pullback followed profit-taking after positive Phase 3 clinical trial developments.\n• Annual revenue stands at $1.94 billion alongside a net profit of $-2.82 billion.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262136721-market-movers-mrna-20260827","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","GNOM","LGHT","BK4568","BK4548","BK4501","IDNA","BK4139","MRNX","WDNA","BK4532","BK4585","MRNY","BK4534","MRNA","BK4588","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662017084","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662017084","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662017084?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:03","pubTimestamp":1787850204,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index decreasing 0.8% and the State Street Health Care Select Sector SPDR ETF  shedding 0.7%.The iShares Biotechnology ETF  was fractionally lower.In corporate news, Moderna  shares fell 5.6% after it said Thursday it plans to offer $2 billion worth of convertible senior notes due 2032 in a private placement.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4534","MRNA","LU0029874061.USD","STT","LGHT","MRNX","XLV","BK4585","LABU","MRNY","LU0128526141.USD","BK4551","BK4581","IDNA","HCSG","FDN","GNOM","BK4532","BK4568","BK4137","BK4533","WDNA","BK4588","BK4139","BK4548","IBB","BK4501","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}